Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
837.3 USD | +0.66% | +2.73% | +43.64% |
08:15am | US FDA Staff Flags Potential Limited Benefit of Eli Lilly's Alzheimer's Disease Drug | MT |
Jun. 06 | US FDA panel to vote on data, risk profile of Lilly Alzheimer's drug | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+43.64% | 754B | |
+39.15% | 630B | |
-6.58% | 352B | |
+19.72% | 331B | |
+8.78% | 298B | |
+11.74% | 217B | |
-1.80% | 216B | |
+0.03% | 163B | |
+6.13% | 164B | |
+0.92% | 124B |
- Stock Market
- Equities
- LLY Stock
- News Eli Lilly and Company
- Jefferies Raises Eli Lilly's Price Target to $895 From $885, Buy Rating Kept